2023 Form 5500 filing — Eyepoint Pharmaceuticals Us, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002082423NAL0008515425001) for Eyepoint Pharmaceuticals Us, Inc. 401(K) Plan, reported by Eyepoint Pharmaceuticals Us, Inc. under EIN 06-1357485 and plan number 001. It reports 193 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$22.4MReported net assets$22,358,068
Participants193
Provider compensation$35.2K2 Schedule C row(s)$35,205
Schedules filedSchedule H, Schedule CLoaded schedules
- EFAST2 acknowledgement
- 20241002082423NAL0008515425001
- Plan sponsor
- Eyepoint Pharmaceuticals Us, Inc.
- EIN
- 06-1357485
- Plan number
- 001
- Location
- Watertown, MA
- Received date
- not reported in the loaded dataset
Schedule H · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$22.4M total assets
Net assets$22.4MLiabilities$0
Full reported line items
- Total assets (EOY)
- $22,358,068
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $22,358,068
- Employer contributions
- $1,432,258
- Participant contributions
- $2,147,853
- Total income / additions
- $7,403,792
- Benefits paid
- $4,622,146
- Administrative expenses
- $42,867
- Total expenses
- $4,665,013
- Net increase / (decrease)
- $2,738,779
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $27,350 | $0 |
| Creative Planning LLC | ADVISOR | $7,855 | not reported in the loaded dataset |